HGF-Induced PD-L1 Expression in Head and Neck Cancer: Preclinical and Clinical Findings

Head and neck squamous cell carcinoma (HNSCC) is a widespread disease with a low survival rate and a high risk of recurrence. Nowadays, immune checkpoint inhibitor (ICI) treatment is approved for HNSCC as a first-line treatment in recurrent and metastatic disease. ICI treatment yields a clear surviv...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Int J Mol Sci
Hoofdauteurs: Boschert, Verena, Teusch, Jonas, Aljasem, Anwar, Schmucker, Philipp, Klenk, Nicola, Straub, Anton, Bittrich, Max, Seher, Axel, Linz, Christian, Müller-Richter, Urs D. A., Hartmann, Stefan
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: MDPI 2020
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7699574/
https://ncbi.nlm.nih.gov/pubmed/33233528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21228770
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items